SCHEMBL670522

SCHEMBL670522

COc1cccc(C(=O)C(C)CN(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
CHRNA1 P02708 1/20 0.52
CHRNG P07510 1/20 0.52
CHRNB1 P11230 1/20 0.52
CHRNB2 P17787 1/20 0.52
SLC6A2 P23975 1/20 0.52
CHRNB4 P30926 1/20 0.52
CHRNA3 P32297 1/20 0.52
CHRNA4 P43681 1/20 0.52
SLC6A3 Q01959 1/20 0.52
CHRND Q07001 1/20 0.52
PARP1 P09874 1/20 0.51
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
CTNNB1 P35222 1/20 0.47
WNT3A P56704 1/20 0.47
TAS1R3 Q7RTX0 1/20 0.47
TAS1R1 Q7RTX1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL670521 1.00 CES2 (0.54) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL12393864 1.00 CES2 (0.54) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL30181112 1.00 CES2 (0.54) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL16740929 1.00 CES2 (0.54) CES2CES1CHRNA1CHRNGCHRNB1
Hydrochloric Acid SCHEMBL671151 0.99 CES2 (0.53) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL670343 0.89 NPC1 (0.44) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL2411119 0.87 TP53 (0.49) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL670344 0.87 TP53 (0.49) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL30515227 0.87 TP53 (0.49) CES2CES1CHRNA1CHRNGCHRNB1
SCHEMBL10855246 0.84 KDM4E (0.54) MEN1KMT2ACYP2D6HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4116288-A1 RACEMIZATION OF (S) AND/OR (R)-3-(DIMETHYLAMINO)-1-(3-METHOXYPHENYL)-2-METHYLPROPAN-1- ONE AND ITS MIXTURES KRKA, d.d., Novo mesto (SI) 2023-01-11 EP claimed
WO-2015075678-A1 A NOVEL PROCESS FOR THE PREPARATION OF 1-PHENYL-3-AMINOPROPANE DERIVATIVES UNIMARK REMEDIES LTD. (IN) 2015-05-28 WO claimed
WO-2013111161-A2 PROCESS FOR THE PREPARATION OF 3-ARYL-2-METHYL-PROPANAMINE DERIVATIVES AND POLYMORPHS THEREOF MSN LABORATORIES LIMITED (IN) 2013-08-01 WO claimed
EP-3210965-B2 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2026-05-13 EP disclosed
EP-3868739-B1 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2023-10-04 EP disclosed
EP-3868739-B1 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2023-10-04 EP disclosed
US-11739049-B2 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol Grünenthal GmbH (DE) 2023-08-29 US disclosed
US-11739049-B2 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol Grünenthal GmbH (DE) 2023-08-29 US disclosed
EP-4116288-A1 RACEMIZATION OF (S) AND/OR (R)-3-(DIMETHYLAMINO)-1-(3-METHOXYPHENYL)-2-METHYLPROPAN-1- ONE AND ITS MIXTURES KRKA, d.d., Novo mesto (SI) 2023-01-11 EP disclosed
EP-4116288-A1 RACEMIZATION OF (S) AND/OR (R)-3-(DIMETHYLAMINO)-1-(3-METHOXYPHENYL)-2-METHYLPROPAN-1- ONE AND ITS MIXTURES KRKA, d.d., Novo mesto (SI) 2023-01-11 EP disclosed
EP-3210965-B1 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2021-11-17 EP disclosed
EP-1069106-B1 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity GRUENENTHAL GMBH (DE) 2004-01-28 EP disclosed
EP-0799819-B1 1-Dimethylaminomethyl 2-phenyl cycloalk-2-ene derivatives with analgesic activity GRUENENTHAL GMBH (DE) 2002-09-11 EP disclosed
EP-0864559-B1 Substituted amino compounds and their use as analgesic active substances GRUENENTHAL GMBH (DE) 2002-06-05 EP disclosed
EP-1069106-A2 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity Grünenthal GmbH (DE) 2001-01-17 EP disclosed
EP-0983995-A2 Pharmaceutically-active dimethyl-(3-aryl-but-3-enyl)-amine compounds Grünenthal GmbH (DE) 2000-03-08 EP disclosed
US-6022895-A Substituted amino compounds and their use as substances having an analgesic effect GRUENENTHAL GMBH (DE) 2000-02-08 US disclosed
US-5811582-A ANALGESICS GRUENENTHAL GMBH (DE) 1998-09-22 US disclosed
EP-0864559-A1 Substituted amino compounds and their use as analgesic active substances Grünenthal GmbH (DE) 1998-09-16 EP disclosed
EP-0799819-A1 Dimethyl-(3-aryl-but-3-enyl) amine derivatives with analgesic activity Grünenthal GmbH (DE) 1997-10-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739049-B2 Process for the preparation of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol COMT, CYP1A1, CYP2E1 CES2 544/4885CES1 754/4885CHRNA1 1732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.